- Q1 2024 Neuropace Inc Earnings Call TranscriptMay 08, 2024$12.6 (-5.26%)Earnings
- Q4 2023 Neuropace Inc Earnings Call TranscriptMar 05, 2024$14.2 (+2.38%)Earnings
- Neuropace Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Neuropace Inc Earnings Call TranscriptNov 06, 2023$7.2 (+0.42%)Earnings
- Q2 2023 Neuropace Inc Earnings Call TranscriptAug 08, 2023$4.1Earnings
- Q1 2023 Neuropace Inc Earnings Call TranscriptMay 04, 2023$4.99 (+2.67%)Earnings
- Neuropace Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Neuropace Inc Earnings Call TranscriptMar 02, 2023$4.2 (-11.21%)Earnings
- Neuropace Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Neuropace Inc Earnings Call TranscriptNov 08, 2022$2.53 (+8.58%)Earnings
- Neuropace Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Neuropace Inc Earnings Call TranscriptAug 11, 2022$5.89 (+3.70%)Earnings
- Neuropace Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Neuropace Inc Earnings Call TranscriptMay 12, 2022$6.26 (+2.96%)Earnings
- Q4 2021 Neuropace Inc Earnings Call TranscriptMar 10, 2022$7.61 (-6.63%)Earnings
- Neuropace Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2022
- Q3 2021 Neuropace Inc Earnings Call TranscriptNov 10, 2021$15.8 (-4.24%)Earnings
- Neuropace Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Neuropace Inc Earnings Call TranscriptAug 12, 2021$21.66 (-2.56%)Earnings
- Q1 2021 Neuropace Inc Earnings Call TranscriptJun 03, 2021$21.67 (-3.65%)Earnings
Q1 2021 Neuropace Inc Earnings Call Transcript
Good morning, and welcome to NeuroPace's First Quarter Earnings Conference Call. (Operator Instructions) We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Matt Bacso from Gilmartin Group for a few introductory comments.
Thanks, operator. Good morning, and thank you for participating in today's call. Joining me from NeuroPace are Mike Favet, CEO; and Rebecca Kuhn, CFO. Earlier today, NeuroPace released financial results for the quarter ended March 31, 2021. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)